Products

share on google plus
Text size
view with small font size
view with medium font size
view with large font size

ABSTRAL®

ABSTRAL® is the novel, rapidly-disintegrating, sublingual (under the tongue) formulation of fentanyl, a well-established opioid used for the management of episodes of breakthrough pain experienced by cancer patients who are already receiving opioid analgesics for chronic pain.

Abstral® SUBLINGUAL FENTANYL CITRATE TABLET

Marketed by Kyowa Hakko Kirin in

  • Japan

Marketed by Kyowa Kirin International in

Worldwide Locations

To Page Top